WallStSmart
ARDX

Ardelyx Inc

NASDAQ: ARDX · HEALTHCARE · BIOTECHNOLOGY

$6.01
+0.67% today

Updated 2026-04-29

Market cap
$1.47B
P/E ratio
P/S ratio
3.62x
EPS (TTM)
$-0.26
Dividend yield
52W range
$3 – $8
Volume
3.6M

Ardelyx Inc (ARDX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+38.0%
Last 4 quarters
Revenue YoY growth
+7.8%
Most recent quarter
EPS YoY growth
-108.5%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+5.0%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+22.2%
2025-10-30
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-11$-0.00+91.4%$6.12$5.66-7.5%
2025-10-30$-0.00+93.0%$4.96$6.06+22.2%
2025-07-30$-0.08+34.4%$4.22$4.24+0.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.02$-0.00+91.4%$125.22M+7.8%
2025-09-30$-0.06$-0.00+93.0%$110.33M+12.3%
2025-06-30$-0.12$-0.08+34.4%$97.66M+33.4%
2025-03-31$-0.15$-0.17-13.3%$74.11M+61.0%
2024-12-31$-0.00$0.02+2957.1%$116.13M+237.9%
2024-09-30$-0.05$-0.00+93.2%$98.24M+74.2%
2024-06-30$-0.11$-0.07+36.4%$73.22M+227.9%
2024-03-31$-0.15$-0.11+26.7%$46.02M+304.8%
2023-12-31$-0.09$-0.12-33.3%$34.36M
2023-09-30$-0.11$0.03+127.3%$56.39M
2023-06-30$-0.11$-0.08+27.3%$22.33M
2023-03-31$-0.10$-0.13-30.0%$11.37M

Frequently asked questions

Has Ardelyx Inc beaten earnings estimates?
Ardelyx Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +38.0% over the last 3 quarters.
How does ARDX stock react to earnings?
ARDX stock has moved an average of +5.0% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Ardelyx Inc's revenue growth rate?
Ardelyx Inc reported year-over-year revenue growth of +7.8% in its most recent quarter, with EPS growing -108.5% year-over-year.